Tag Archives: Bristol

MHRA gives Bristol Labs the all-clear

Bristol Laboratories is back in business in the U.K. The U.K. generic drug maker, whose partial suspension by European regulators in 2017 led to shortages of some drugs, has passed its latest Medicines and Healthcare products Regulatory Agency (MHRA) inspection. Bristol Director of Quality and Regulatory Affairs Priti Ramachandran said the company “welcomes the full… Read More »